40
Participants
Start Date
July 31, 2010
Primary Completion Date
November 30, 2010
Study Completion Date
November 30, 2010
PF-03463275
Oral single 20 mg dose as two 10mg controlled release tablets
PF-03463275
Oral single 40 mg dose as four 10mg controlled release tablets
PF-03463275
Oral single 60 mg dose as six 10mg controlled release tablets
Placebo
Oral single dose as matching placebo
PF-03463275
Oral multiple 40 mg doses as four 10mg controlled release tablets for 7 days
Placebo
Oral multiple doses as matching placebo for 7 days
Pfizer Investigational Site, Glendale
Lead Sponsor
Pfizer
INDUSTRY